156 related articles for article (PubMed ID: 3875399)
21. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
22. Kinetic correlates of methotrexate transport and therapeutic responsiveness in murine tumors.
Sirotnak FM; Donsbach RC
Cancer Res; 1976 Mar; 36(3):1151-8. PubMed ID: 943237
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of folate transport in rabbit reticulocytes.
Bobzien WF; Goldman ID
J Clin Invest; 1972 Jul; 51(7):1688-96. PubMed ID: 5032520
[TBL] [Abstract][Full Text] [Related]
24. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
25. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
Yang CH; Dembo M; Sirotnak FM
J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
[TBL] [Abstract][Full Text] [Related]
26. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells.
Henderson GB; Zevely EM
Biochem Int; 1983 Apr; 6(4):507-15. PubMed ID: 6679721
[TBL] [Abstract][Full Text] [Related]
27. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
Henderson GB; Suresh MR; Vitols KS; Huennekens FM
Cancer Res; 1986 Apr; 46(4 Pt 1):1639-43. PubMed ID: 3948153
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
29. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system.
Sirotnak FM; Moccio DM; Yang CH
J Biol Chem; 1984 Nov; 259(21):13139-44. PubMed ID: 6490649
[TBL] [Abstract][Full Text] [Related]
30. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
31. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
[TBL] [Abstract][Full Text] [Related]
33. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
35. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study.
Moccio DM; Sirotnak FM; Samuels LL; Ahmed T; Yagoda A; DeGraw JI; Piper JR
Cancer Res; 1984 Jan; 44(1):352-7. PubMed ID: 6690047
[TBL] [Abstract][Full Text] [Related]
36. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
Sirotnak FM; Donsbach RC
Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
[No Abstract] [Full Text] [Related]
37. Two-compartment behavior during transport of folate compounds in L1210 cell plasma membrane vesicles.
Yang CH; Dembo M; Sirotnak FM
J Membr Biol; 1982; 68(1):19-28. PubMed ID: 6980990
[TBL] [Abstract][Full Text] [Related]
38. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
Samuels LL; Moccio DM; Sirotnak FM
Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
[TBL] [Abstract][Full Text] [Related]
39. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
[TBL] [Abstract][Full Text] [Related]
40. Role of the amino acid 45 residue in reduced folate carrier function and ion-dependent transport as characterized by site-directed mutagenesis.
Zhao R; Gao F; Wang PJ; Goldman ID
Mol Pharmacol; 2000 Feb; 57(2):317-23. PubMed ID: 10648641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
